Argentina has become the latest success story for surgical sealant specialist Tissuemed. With the help of our local partner, BIOX, we have secured approval for the TissuePatch product family of surgical sealant films including TissuePatch™ and TissuePatchDural™.
Dr David Mandley Tissuemed’s CEO commented: “We’re delighted to have been granted approval by ANMAT and thank our Argentine distributor for their support and commitment to the project. With a population approaching 45 million and healthcare expenditure accounting for 7% of GDP – among the highest in the region, Argentina is an attractive export market, particularly as ¾ of all medical products used are imported”.
Pictured are sales colleagues from Tissuemed’s Argentinian partner, BIOX, getting ‘hands-on’ with TissuePatch products during a recent product training session.